期刊文献+

应用蛋白质组学技术研究HL-60细胞及其耐阿霉素细胞株的蛋白表达差异 被引量:3

Differential Protein Expressions between HL-60 Cells and Adriamycin-Resistant HL-60 Cells by Proteomic Analysis
下载PDF
导出
摘要 目的比较人髓系白血病细胞株HL-60细胞和耐阿霉素的细胞(HL-60/ADR)的整体蛋白表达谱,以期获得人髓系白血病细胞的耐药相关蛋白。方法提取HL-60细胞和HL-60/ADR细胞的总蛋白,采用荧光差异显示的双向凝胶电泳技术(DIGE)比较分析差异表达蛋白;经胶内酶解,MALDI-TOF/TOF质谱分析,搜索蛋白质数据库,获得差异蛋白质的信息。结果经过初步筛选和质谱分析共获得16个具有统计学意义的表达差异蛋白点,其中13个在HL-60细胞中表达上调,3个表达下调。主要是代谢酶类、DNA修复、信号转导相关蛋白、细胞周期调节蛋白和细胞增殖与凋亡等相关的蛋白。结论根据人髓系白血病细胞株HL-60细胞和HL-60/ADR细胞的差异蛋白表达谱比较,筛选出耐药相关蛋白。 Objective To compare the protein expression profiles between human myeloid leukemia HL-60 cells and adriamycin-resistant HL-60 cells and to explore drug resistance-associated proteins in myeloid leukemia. Methods Total cellular proteins extracted from HL-60 and adriamycin-resistant HL-60 cells were separated by two dimensional differences in gel electrophoresis (2D DIGE). Differe- nialtly expressed proteins were analyzed by mass spectrometry (MALDI-TOF/TOF), and protein database searching. Results Sixteen significantly different protein expression spots were screened, among which thirteen protein spots were identified to be up-regulated and three down-regulated in adriamycin-resistant HL-60 cells. The identified proteins were metabolic enzymes, DNA repairs, proteins related with signal transduction, cell cycle regulator, and cellular proliferation and apoptosis proteins. Conclusion 2D DIGE is a useful approach to investigate different protein expression-related treatment of resistance and could provide a novel clue of the resistant mechanisms in myeloid leukemia.
出处 《福建医科大学学报》 2009年第1期1-4,共4页 Journal of Fujian Medical University
基金 国家自然科学基金(30572132) 福建省自然科学基金(C0410029) 福建医科大学基金(FJGXY04022)
关键词 HL-60白血病细胞 白血病 电泳 凝胶 双向 蛋白质组学 多药耐药相关蛋白质类 HL-60 leukemic cells leukemia electrophoresis,gel, two-dimensional proteomics multidrug resistance-associated proteins
  • 相关文献

参考文献14

  • 1Kourti M, Vavatsi N, Gombakls N, et al. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia[J]. Int J Hematol, 2007,86(2):166-173.
  • 2苏丽萍,王玉萍,乔振华,张丽,朱镭,鹿育晋,周永安.急性髓系白血病细胞内柔红霉素潴留与多药耐药关系的研究[J].中华血液学杂志,2005,26(8):497-498. 被引量:3
  • 3秦慧,刘霆,杨金亮,黄欣,柳斌,宋鑫,赵霞,魏于全.蛋白质组学方法筛选维甲酸耐药相关蛋白[J].中华医学杂志,2007,87(8):520-525. 被引量:8
  • 4Harris M N, Ozpolat B, Abdi F, et al. Comparative proteomic analysis of alt-trans-retinoic acid treatment reveals systematic posttranseriptional control mechanisms in acute promyelocytic leukemia[J]. Blood, 2004,104(5):1314-1323.
  • 5Tonge R, Shaw J, Middleton B,et al. Validation and development of fluorescence two-dimensional differential gel electro phoresis proteomies technology[J]. Proteomics, 2001,1(3) 377-396.
  • 6Kondo T,Hirohashi S. Application of highly sensitive fluorescent dyes (CyDye DIGE fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics[J]. Nat Protoc, 2006, 1 (6) :2940-2956.
  • 7Alban A,David S O,Bjorkesten L,et al. A novel experimental design for comparative two-dimensional gel analysis., two-dimensional difference gel electrophoresis incorporating a pooled internal standard[J]. Proteomics, 2003,3 (1): 36-44.
  • 8Verrills N M,Walsh B J,Cobon G S,et al. Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel eytoskeletal alterations[J]. J Biol Chem, 2003,278(46) :45082-45093.
  • 9Rousseau B, Menard L, Haurie V, et al. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma[J]. Hepatology, 2007, 46 (4):1108-1118.
  • 10Otake Y, Sengupta T K, Bandyopadhyay S, et al. Retinoid-Induced apoptosis in HL-60 cells is associated with nucleolin down-regulation and destabilization of Bcl-2 mRNA[J]. Mol Pharm, 2005,67(1) 1319-326.

二级参考文献18

  • 1Michieli M, Damiani D, Ermacora A, et al. P-glycoprotein (P-gp)and lung resistance -related protein (LRP) and multidrug resistanceassociated protein (MRP) expression in acute promyelocytic leukemia. Br J Haemato1,2000,108: 703-709.
  • 2Borg AG, Burgess R, Green LM, et al. P-glycoprotein and multidrug resistance -associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukemic cells. Br J Haematol,2000, 108:48-54.
  • 3Kirchhoff SR, Gupta S , Knowlton AA. Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation, 2002,105 : 2899-2904.
  • 4Kinumi T, Kimata J, Taira T, et al. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells.Biochem Biophys Res Commun, 2004, 317: 722-728.
  • 5Groenendyk J, Lynch J , Michalak M. calreticulin, Ca^2+ and calcineurin signaling from the Endoplasmic Reticulum. Mol Cells,2004, 17: 383-389.
  • 6Burns K, Duggan B, Atkinson E, et al. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor.Nature, 1994, 367 : 476-480.
  • 7Bandopadhyay R, Kingsbury AE, Cookson MR, et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain, 2004, 127 : 420-430.
  • 8Arnaudeau S, Frieden M, Nakamura K, et al. Calreticulin Differentially Modulates Calcium Uptake and Release in the Endoplasmic Reticulum and Mitochondria. J Biol Chem, 2002,277 : 46696-46705.
  • 9Desai D, Michalak M, Singh NK, et al. Inhibition of Retinoic Acid Receptor Function and Retinoic Acid-regulated Gene Expression in Mouse Melanoma Cells by Calreticulin. J Biol Chem, 1996, 271 : 15153-15159.
  • 10Lau TY, He QY, Chiu JF. Proteomic Technology and Its Biomedical Applications. Acta Biochimica et Biophysica Sinica,2003, 35: 965-975.

共引文献9

同被引文献21

  • 1Li J,Sejas DP,Rani R,et al.Nucleophosmin regulates cell cycleprogression and stress response in hematopoietic stem/progenitorcells.J Biol Chem,2006;281(24):16536-16545.
  • 2Okuwaki M,Matsumoto K,Tsujimoto M,et al.Function ofnucleophosmin/B23,a nucleolar acidic protein,as a histonechaperone.FEBS Lett,2001;506(3):272-276.
  • 3Grisendi S,Mecucci C,Falini B,et al.Nucleophosmin andcancer.Nat Rev Cancer,2006;6(7):493-505.
  • 4Yang YX,Hu HD,Zhang DZ,et al.Identification of proteinsresponsible for the development of adriamycin resistance in humangastric cancer cells using comparative proteomics analysis.JBiochem Mol Biol,2007;40(6):853-860.
  • 5Hu J,Lin M,Liu T,et al.DIGE-based proteomic analysisidentifies nucleophosmin/B23 and nucleolin C23 as over-expressedproteins in relapsed/refractory acute leukemia.Leuk Res,2011;35(8):1087-1092.
  • 6Grisendi S,Bernardi R,Rossi M,et al.Role of nucleophosmin inembryonic development and tumorigenesis.Nature,2005;437(7055):147-153.
  • 7Okuwaki M.The structure and functions of NPM1/Nucleophsmin/B23,a multifunctional nucleolar acidic protein.J Biochem.2008;143(4):441-448.
  • 8Hsu CY,Yung BY.Over-expression of nucleophosmin/B23decreases the susceptibility of human leukemia HL-60 cells toretinoic acid-induced differentiation and apoptosis.Int J Cancer.2000;88(3):392-400.
  • 9Hsu CY,Yung BY.Involvement of nucleophosmin/B23 in TPA-induced megakaryocytic differentiation of K562 cells.Br J Cancer.2003;89(7):1320-1326.
  • 10Liu WH,Hsu CY,Yung BY.Nucleophosmin/B23 regulates thesusceptibility of human leukemia HL-60 cells to sodium butyrate-induced apoptosis and inhibition of telomerase activity.Int JCancer.1999;83(6):765-771.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部